This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2ovv
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /><applet load="2ovv" size="350" color="white" frame="true" align="right" spinBox="true" caption="2ovv, resolution 2.000Å" /> '''Crystal structure o...)
Next diff →
Revision as of 19:16, 29 January 2008
|
Crystal structure of the catalytic domain of rat phosphodiesterase 10A
Overview
A papaverine based pharmacophore model for PDE10A inhibition was generated, via SBDD and used to design a library of, 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether, pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for, additional modeling, X-ray, and synthetic efforts toward increasing PDE10A, inhibitory potency and selectivity versus PDE3A/B. These efforts, culminated in the discovery of 29, a potent and selective brain penetrable, inhibitor of PDE10A.
About this Structure
2OVV is a Single protein structure of sequence from Rattus norvegicus with , , and as ligands. Active as 3',5'-cyclic-nucleotide phosphodiesterase, with EC number 3.1.4.17 Full crystallographic information is available from OCA.
Reference
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors., Chappie TA, Humphrey JM, Allen MP, Estep KG, Fox CB, Lebel LA, Liras S, Marr ES, Menniti FS, Pandit J, Schmidt CJ, Tu M, Williams RD, Yang FV, J Med Chem. 2007 Jan 25;50(2):182-5. PMID:17228859
Page seeded by OCA on Tue Jan 29 21:16:47 2008
